Sharechat Logo

Fisher's Kingfish introduces quarterly dividends

Wednesday 24th June 2009

Text too small?

Fund manager Carmel Fisher’s Kingfish, the small cap investor managed by Fisher Funds, will offer quarterly dividend payments to investors, with first return likely to be made in September.

The new long-term distribution policy will pay 8% of its average net asset value over four quarters, and will allow investors to access a portion of their investment every year, said chairman Rob Challinor in a statement.

The offer isn’t compulsory, and shareholders will be able to retain their long-term focus if they choose.  

“We don’t expect all Kingfish shareholders will want to receive a cash distribution so a distribution reinvestment programme will continue to be offered,” said Fisher.  

The fund manager had a disappointing 12 months as its NAV fell 25% to 92 cents in the year ended March 31 and cut its dividend to 4.5 cents per share.  It recorded a 9.8% increase to $1.01 in its June 17 update.  

Parent company Fisher Funds hadn’t decided whether to extend the scheme to shareholders in its other two NZX-listed companies Barramundi and Marlin Global, and would monitor the uptake among Kingfish investors.  

“It’s new and a bit different so we’ll take a watch this space attitude before considering whether it is appropriate for the shareholders of the other listed funds.” said Challinor.

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report